Fw: GVAX lung cancer vaccine clinical trial

[Guest guest]

anyone know more about this???

GVAX lung cancer vaccine clinical trial

> The GVAX lung cancer vaccine trial is open to patients with stage III B or

> IV non-small cell lung cancer. Patients must have either a pleural

effusion

> of at least 600cc or a superficial tumor such as a supraclavicular lymph

> node or cutaneous tumor that can be surgically removed for vaccine

> production. The surgery cannot be in an area that has received radiation

> therapy. The surgery for tumor procurement and all treatment must be done

at

> a participating center in the U.S. Please check our website at

www.mcmrc.com

> for additional information on this trial and other clinical trials that

may

> be of interest to you. Patients should continue with the treatment as

> prescribed by their physician while looking into these other options. If

you

> wish to schedule a consultation please provide a day time telephone

number,

> and someone from our office will call. The attached file indicates the

> medical records you will need to bring with you to the consultation.

Please

> understand that if you are accepted into this program you would be

required

> to stay here during the course of the treatment, which can be several

> months, depending upon the trial chosen.

>

> Thank you for your interest in our program.

>

> Ned , RN

>

> Clinical Research Coordinator

> Crowley Medical Research Center

> 3535 Worth Street

> Building Suite 302

> Dallas, TX 75246

> 214-370-1815 phone

> 214-370-1860 fax

>

> .